Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Engineered Erythrocytes As an Anti-Tumor Therapy through Induction of Apoptosis or Immune-Checkpoint Inhibition

Sivan Elloul, PhD, Claire Depew, BSc, Sujata Nerle, MSc, Tiffany Chen, PhD, Samuel Kaplan, BSc, Nathan Dowden, MBA, Jordi Mata-Fink, PhD, Avak Kahvejian, PhD, Robert Deans, PhD

Blood (2016) 128 (22): 2166.

https://doi.org/10.1182/blood.V128.22.2166.2166

Published: 2016

Journal Articles

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

Richard T. Maziarz, MD, Timothy deVos, M.D., Carlos Bachier, MD, Steven C. Goldstein, MD, Jose F. Leis, MD, PhD, Robert Perry, B.S., Robert Deans, PhD, Wouter J Van't Hof, PhD, Hillard M. Lazarus, MD

Blood (2011) 118 (21): 1987.

https://doi.org/10.1182/blood.V118.21.1987.1987

Published: 2011

Journal Articles

Inflammatory Cell Tissue Extravasation Pathways Can Be Regulated by Adherent Stem Cells by Inhibiting Selectin Ligand and Adhesion Receptor Expression On T Cells and Activated Endothelium.

Wouter Van't Hof, PhD, Amy Raber, MS, Juliana Woda, PhD, Nicholas Lehman, BA, Rochelle Cutrone, BA, Anthony Ting, PhD, Robert Deans, PhD

Blood (2009) 114 (22): 3631.

https://doi.org/10.1182/blood.V114.22.3631.3631

Published: 2009

Journal Articles

Genomics Analysis of Freshly-Purified Human Marrow Stromal Cells (MSCs): Comparison with Hematopoietic Lineage Cells and Culture-Expanded MSCs.

Elena A. Jones, PhD, Sally E. Kinsey, MD, Anne English, FIBMS, Sarah Field, BSc, Andy Rawstron, PhD, Richard A. Jones, PhD, Liz Strazsynski, BSc, Stephen Rundlett, PhD, Selina Jain, Robert Deans, PhD, Paul Emery, MD, Frederique Ponchel, PhD, Dennis McGonagle, PhD

Blood (2006) 108 (11): 2570.

https://doi.org/10.1182/blood.V108.11.2570.2570

Published: 2006

Journal Articles

Direct Injection of Allogeneic Multipotent Adult Progenitor Cells Improves Cardiac Function after Myocardial Infarct.

Wouter van’t Hof, PhD, Niladri Mal, PhD, Ming Zhang, PhD, Farhad Forudi, PhD, Robert Deans, PhD, Marc Penn, MD

Blood (2005) 106 (11): 2206.

https://doi.org/10.1182/blood.V106.11.2206.2206

Published: 2005

NARROW

Engineered Erythrocytes As an Anti-Tumor Therapy through Induction of Apoptosis or Immune-Checkpoint Inhibition

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

Inflammatory Cell Tissue Extravasation Pathways Can Be Regulated by Adherent Stem Cells by Inhibiting Selectin Ligand and Adhesion Receptor Expression On T Cells and Activated Endothelium.

Genomics Analysis of Freshly-Purified Human Marrow Stromal Cells (MSCs): Comparison with Hematopoietic Lineage Cells and Culture-Expanded MSCs.

Direct Injection of Allogeneic Multipotent Adult Progenitor Cells Improves Cardiac Function after Myocardial Infarct.

Email alerts

ASH Publications

American Society of Hematology

Engineered Erythrocytes As an Anti-Tumor Therapy through Induction of Apoptosis or Immune-Checkpoint Inhibition

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

Inflammatory Cell Tissue Extravasation Pathways Can Be Regulated by Adherent Stem Cells by Inhibiting Selectin Ligand and Adhesion Receptor Expression On T Cells and Activated Endothelium.

Genomics Analysis of Freshly-Purified Human Marrow Stromal Cells (MSCs): Comparison with Hematopoietic Lineage Cells and Culture-Expanded MSCs.

Direct Injection of Allogeneic Multipotent Adult Progenitor Cells Improves Cardiac Function after Myocardial Infarct.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only